Consistency of effect of ezetimibe/simvastatin compared with intensified lipid-lowering treatment strategies in obese and non-obese diabetic subjects

PURPOSE: This post hoc analysis assessed switching to ezetimibe/simvastatin 10/20 mg vs doubling the baseline statin dose to simvastatin 40 mg or atorvastatin 20 mg or switching to rosuvastatin 10 mg in subgroups of obese (BMI ≥30 kg/m(2)) and non-obese (BMI <30 kg/m(2)) diabetic subjects. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosen, Jeffrey B, Jimenez, Jose G, Pirags, Valdis, Vides, Hella, Massaad, Rachid, Hanson, Mary E, Brudi, Philippe, Triscari, Joseph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3722050/
https://www.ncbi.nlm.nih.gov/pubmed/23866306
http://dx.doi.org/10.1186/1476-511X-12-103

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3722050/
https://www.ncbi.nlm.nih.gov/pubmed/23866306
http://dx.doi.org/10.1186/1476-511X-12-103

Ejemplares similares